Product image of Jansitin (Sitagliptin) supplied by GNH India

Jansitin

Active Ingredient:
Sitagliptin
Origin:
EU

Jansitin (Sitagliptin)

Sitagliptin, the active ingredient in Jansitin, is a dipeptidyl peptidase-4 (DPP‑4) inhibitor presented as a strength/form for oral use. It treats type 2 diabetes mellitus in adults by improving glycemic control.

GNH India supplies Jansitin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

G.L. Pharma Gmbh

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Jansitin is a DPP‑4 inhibitor used in the management of type 2 diabetes mellitus, acting on the incretin pathway to improve blood glucose regulation.

  • Type 2 diabetes mellitus (monotherapy): lowers HbA1c and fasting glucose when used with diet and exercise.
  • Combination therapy with metformin: enhances glycemic control in patients inadequately controlled on metformin alone.
  • Adjunct to insulin therapy: may improve overall glucose management when added to insulin regimens.

How It Works

  • Sitagliptin selectively inhibits the dipeptidyl peptidase‑4 (DPP‑4) enzyme, preventing the breakdown of the incretin hormones GLP‑1 and GIP. Elevated incretin levels increase glucose‑dependent insulin secretion, suppress glucagon release, and slow gastric emptying, resulting in lowered post‑prandial and fasting blood glucose concentrations.

Side Effects

Adverse reactions to Jansitin may vary in frequency and severity.

Common Side Effects

  • Nasopharyngitis: mild inflammation of the upper airway.
  • Headache: transient mild to moderate pain.
  • Upper respiratory tract infection: symptoms of cough and congestion.
  • Gastrointestinal upset: nausea, abdominal discomfort.
  • Dizziness: occasional light‑headedness.

Serious or Rare Side Effects

  • Pancreatitis: severe abdominal pain requiring immediate medical attention.
  • Severe allergic reactions: including rash, angioedema, or anaphylaxis.
  • Hepatic injury: elevated liver enzymes or jaundice.
  • Bullous pemphigoid: blistering skin disorder.
  • Severe joint pain: unexplained arthralgia that may be disabling.

Precautions & Warnings

Before initiating Jansitin, consider the following safety measures.

  • Renal impairment: dose adjustment may be required based on creatinine clearance.
  • Hepatic disease: use with caution in patients with liver dysfunction.
  • History of pancreatitis: avoid use due to potential recurrence.
  • Concomitant insulin or sulfonylureas: monitor for hypoglycemia.
  • Pregnancy and lactation: safety not established; consult prescriber.
  • Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Avoid Interactions

Jansitin may interact with other medicines; awareness of the interaction level helps guide clinical decisions.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase sitagliptin exposure.
  • Co‑administration with insulin secretagogues (e.g., sulfonylureas): heightened risk of hypoglycemia.
  • Drugs causing severe hypersensitivity reactions: may exacerbate allergic responses.

Moderate Interactions (Monitor Closely)

  • Diuretics: may affect renal clearance of sitagliptin.
  • ACE inhibitors: monitor blood pressure when combined.
  • Warfarin: periodic INR checks recommended.

Frequently Asked Questions

Jansitin contains sitagliptin, a DPP‑4 inhibitor indicated for the treatment of type 2 diabetes mellitus in adults. It is used to improve glycemic control when combined with diet, exercise, and, if needed, other antidiabetic agents.

Sitagliptin blocks the DPP‑4 enzyme, which normally degrades the incretin hormones GLP‑1 and GIP. By preserving these hormones, the drug enhances glucose‑dependent insulin secretion, reduces glucagon release, and helps lower blood glucose levels.

The specific dose of Jansitin is determined by the prescribing clinician based on the patient’s renal function, glycemic targets, and concomitant therapies. Dosage adjustments are made individually and should follow the prescriber’s instructions.

Safety data for sitagliptin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Jansitin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Compared with sulfonylureas, sitagliptin has a lower risk of hypoglycemia because its insulin‑stimulating effect is glucose‑dependent. Unlike metformin, it does not affect gastrointestinal motility, and it can be combined with both agents for additive glucose‑lowering effects.

Jansitin should be stored at ambient temperature below 25 °C, in its original packaging, and protected from moisture and direct sunlight. Do not store in a refrigerator or freezer unless otherwise specified by the manufacturer.

Jansitin is taken orally, usually once daily, with or without food. The tablet should be swallowed whole with a glass of water and not chewed or crushed, unless the prescriber provides alternative instructions.

Serious risks include pancreatitis, severe allergic reactions such as anaphylaxis, and rare cases of hepatic injury. Patients should seek immediate medical attention if they experience persistent abdominal pain, rash, swelling, or jaundice.

Jansitin is contraindicated in patients with a known hypersensitivity to sitagliptin or any component of the formulation. It should also be avoided in individuals with a history of pancreatitis until the cause is clarified.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Sitagliptin

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT